EUPRAXIA PHARMACEUTICALS INC. financial data

Symbol
EPRX on Nasdaq
Location
Victoria, British Columbia, Canada
Fiscal year end
31 December
Latest financial report
40-F - Q4 2025 - 13 Mar 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35,641,603 shares 31%
Common Stock, Shares, Outstanding 51,939,206 shares 46%
Common Stock, Value, Issued $195,406,895 USD 68%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $80,563,482 USD 143%
Accounts Receivable, after Allowance for Credit Loss, Current $716,095 USD 177%
Assets, Current $85,098,550 USD 147%
Property, Plant and Equipment, Net $834,429 USD 133%
Operating Lease, Right-of-Use Asset $152,697 USD 128%
Assets $86,150,008 USD 147%
Accounts Payable, Current $942,201 USD 150%
Liabilities, Current $5,628,005 USD 81%
Operating Lease, Liability, Noncurrent $75,910 USD
Liabilities $5,703,915 USD 84%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,044,137 USD 51%
Retained Earnings (Accumulated Deficit) $169,579,974 USD -29%
Stockholders' Equity Attributable to Parent $82,041,436 USD 146%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $80,446,093 USD 153%
Liabilities and Equity $86,150,008 USD 147%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 51,939,206 shares 46%
Common Stock, Par or Stated Value Per Share 15 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $80,563,482 USD 143%
Deferred Tax Assets, Valuation Allowance $43,366,083 USD 38%
Operating Lease, Liability $154,362 USD 115%
Lessee, Operating Lease, Liability, to be Paid $163,514 USD 120%
Property, Plant and Equipment, Gross $1,478,596 USD 81%
Operating Lease, Liability, Current $78,452 USD 9.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $78,202 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $85,312 USD 15%
Operating Lease, Weighted Average Discount Rate, Percent 0.0605 pure -33%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,152 USD 248%
Deferred Tax Assets, Operating Loss Carryforwards $30,555,303 USD 38%
Preferred Stock, Shares Issued 8,355,638 shares -6.2%
Preferred Stock, Shares Outstanding 8,355,638 shares -6.2%
Deferred Tax Assets, Net of Valuation Allowance $0 USD